Results

Total Results: over 10,000 records

Showing results for "months".

441. Recommendation: Prevention of Dental Caries in Children Younger Than 5 Years: Screening and Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-dental-caries-in-children-younger-than-age-5-years-screening-and-interventions1
     December 07, 2021 - USPSTF recommends that primary care clinicians prescribe oral fluoride supplementation starting at age 6 months … Children younger than 5 years: Grade B Prescribe oral fluoride supplementation starting at age 6 months … Prescribe: Prescribe oral fluoride supplementation beginning at age 6 months to children whose water … In studies, fluoride varnish was most commonly administered as 5% sodium fluoride, every 6 months. 1 … of eruption of the first tooth and no later than age 12 months.

442. A Prioritized Research Agenda for Using the Harmonized Outcome Measures in the Support Patient-Centered Outcomes Research in Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritized-research-agenda.pdf
     October 01, 2021 - ) - Remission rates (at 6 and 12 months) - Rate of suicide ideation and behavior at 12 months Patient-centered … - Remission rates at 12 months - Rate of suicide ideation and behavior at twelve months Patient-centered … Do response rate at 6 months and remission rate at 12 months vary between patients who are screened … , every 6 months versus every 12 months) differ from those were not according to response rate and remission … and 12 months?

443. Evidence-Summary-CER-209-Noninvasive-Nonpharmacological-Treatment-For-Chronic-Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-209-evidence-summary-non-pharma-chronic-pain.pdf
     June 01, 2018 - ), intermediate term (≥6 to <12 months) and long term (≥12 months). … ), intermediate term (≥6 to <12 months) and long term (≥12 months). … ; Intermediate-Term: ≥6 to <12 months; Long-Term: ≥12 months Effect Size: none, slight/small, moderate … ; Intermediate-Term: ≥6 to <12 months; Long-Term: ≥12 months Effect Size: none, slight/small, moderate … ; Intermediate-Term: ≥6 to <12 months; Long-Term: ≥12 months Effect Size: none, slight/small, moderate

444. Using eHealth to Expand Access to Cognitive Behavioral Therapy for Insomnia in Hispanic Primary Care Patients - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/r01hs024274-alcantara-final-report-2024.pdf
     January 01, 2024 - effectiveness of culturally adapted dCBT-I vs. minimally enhanced usual care (mEUC) at 9- weeks and 6-months … of insomnia symptoms and of secondary outcomes were conducted at post- intervention (9 weeks) and 6 months … ; Sleep quality was measured with the PSQI at baseline, 9 weeks, and 6- months. … In early 2023, and only a few months into the start of the RCT, the digital therapeutics firm (Pear … mEUC groups at 6-months.

445. Digestible Carbohydrate Intake and Maternal-Infant Outcomes: Appendix D Tables (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-appendix-d.xlsx
     January 01, 2019 - of age Mean age, months (SD): 4.5 (0.5) vs. 4.5 (0.5) % female: 42% vs. 45% Race/ethnicity: NR Birth … B, 6 months 2941 (525) vs. 2941 (497) 9 months 3472 (498) vs. 3432 (538) Mean, g (SD) A vs. … B, 6 months 87.6 (20.9) vs. 83.1 (16.8) 9 months 113.6 (20.6) vs. 103.4 (18.5), p<0.001 NR NR NR NR … B, 6 months 11.7 (3.0) vs. 13.1 (4.0) 9 months 15.9 (3.6) vs. 21.5 (5.7) NR Mean, g (SD) A vs. … B, 6 months 32.3 (6.0) vs. 33.1 (6.7) 9 months 32.8 (5.4) vs. 33.7 (6.9) NR Latva-Pukkila, 2010 Median

446. A Risk-Based Approach to Improving Management of Chronic Kidney Disease - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/publication/r18hs018226-sequist-final-report-2013.pdf
     January 01, 2013 - This included our primary outcomes of an office visit to a nephrologist within the prior 12 months ( … Appropriate use of ACE inhibitor/ARB use was defined as a prescription within the last 12 months for … Appropriate use of statins was defined as a prescription within the last 12 months for patients with … Active co-management by nephrology within the prior 12 months was more consistently associated with … improved CKD care compared to past nephrology involvement (< 12 months).

447. Using Telemedicine to Promote Patient Centered Care Among Underserved Individuals (pdf file)
     digital.ahrq.gov/sites/default/files/docs/publication/r18hs017202-bove-final-report-2011.pdf
     January 01, 2011 - Change over 6 months: BP Diastolic (mmHg) -4.6±10.3 -7.6±12.3 NS Change over 6 months: MAP (mmHg) … months: Chol Total (mg/dl) -8.2±34.7 -9.5±35.1 NS Change over 6 months: Chol HDL (mg/dl) 1.1±12.2 -0.4 … Change over 6 months: BP Diastolic (mmHg) -5.5±10.1 -5.9±10.8 NS Change over 6 months: MAP (mmHg) … -9.7±10.5 -9.4±12.7 NS Change over 6 months: FBG (mg/dl) -23.8±63.4 -3.6±47.9 NS Change over 6 months … NS Change over 6 months: Chol LDL (mg/dl) -9.2±29.9 -12.9±53.1 NS Change over 6 months: Triglycerides

448. The Use of Conjoint Analysis to Elicit Patient Preferences in Selecting Treatment Endpoints (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/mcda-johnson.pdf
     August 27, 2012 - There is a dashed line across 3-months and 10-months with an arrow pointing upward (from 5 months to … 10 months) with the equation: ∆ = +0.84. … There is a dashed line across 3-months and 10-months with an arrow pointing upward (from 5 months to … 10 months) with the equation: ∆ = +0.84.

449. Healthcare Cost and Utilization Project (HCUP) NRD Notes
     hcup-us.ahrq.gov/db/vars/ecoden/nrdnote.jsp
     August 01, 2015 - In the data prior to 1998, a six months window (three months before and three months after) is allowed … Beginning in the 1998 data, a year window (six months before and six months after) is allowed.

450. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
     February 01, 2019 - ), intermediate-term treatment duration (6 to 12 months), and long-term treatment duration (≥12 months … ), intermediate-term treatment duration (6 to 12 months), and long-term treatment duration (≥12 months … ), intermediate-term treatment duration (6 to 12 months), and long-term treatment duration (≥12 months … ), intermediate-term treatment duration (6 to 12 months), and long-term treatment duration (≥12 months … , 6 to 12 months, and ≥12 months).

451. Time, Effort, and Infrastructure Costs to Use Electronic Health Records (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/Fleming_SS_508_20111021_d.pdf
     June 16, 2021 - Clinicians’ productivity decreased initially, but after 12 months was only slightly (4 percent) below … five physician practice or $46,659 per physician (approximately $2,900/physician/month over the 16 months … by 12 months post-implementation. … after EHR implementation, recovering to 4.5 percent lower than pre-implementation after 12 months. … Net income also decreased initially but after 12 months was not different than pre-EHR levels.

452. Screening and Routine for Iron Deficiency Anemia: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/g-b8KbTXYe2vnW2zJKGoPU
     April 01, 2015 - After 3 to 12 months, Bayley Scales of Infant Development scores were not significantly different in … Iron supplementation was administered for durations ranging from 3 to 18 months. … of IDA in infants and children 6 to 24 months of age were found. … Iron status in a group of Norwegian children aged 6-24 months. … Iron supplementation of breast-fed Honduran and Swedish infants from 4 to 9 months of age.

453. Contact Information for Submission of Clinical Laboratory Data
     hcup-us.ahrq.gov/datainnovations/clinicalcontentenhancementtoolkit/ny5.jsp
     September 01, 2014 - Less than 1 month 1-2 months More than 2 months Cannot send these data to NYSDOH at this time … None, lab is already using v2.5.1 Less than 1 month 1-2 months More than 2 months What is the … target date for HL7 v2.5.1 messaging capability if more than 2 months?

454. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49743/psn-pdf
     September 01, 2015 - he received follow-up from a cardiologist and was informed he should remain on triple therapy for 6 months … to continue the clopidogrel and aspirin (dual anticoagulation therapy [DAPT]) for an additional 6 months … The cardiologist noted that an FDA Advisory Panel recommends just 12 months of DAPT after drug-eluting … stent implantation, due to an increased risk of bleeding after 24 months of DAPT. … and the DAPT to be discontinued after 12 months.

455. A National Conference on the Role of Health IT to Improve Medication Management - Slides (pdf file)
     digital.ahrq.gov/sites/default/files/docs/improve-medication-management-slides-091318.pdf
     September 27, 2018 - PCD for Antihypertensive Medication by Group and Over Time 12-6 months prior 6-0 months prior 0 … Conclusions • Text messaging improved self-reported adherence at 3 months but not at 6 months; pill … • Intervention lasts for 6 months – ensure patient has a “safe landing” back to usual pharmacy. … • Outcomes followed for 6 months: – Discrepancies between documented and dispensed medications. – … Users can adjust the time frame for the graph by clicking ‘Weeks’ or ‘Months.’

456. CPOE Implementation in ICUs - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/r01hs015274-carayon-final-report-2009.pdf
     January 01, 2009 - and 12 months after the implementation. … Analyses of CPOE/EHR acceptance (mean, SD) Nurses: 3 months Nurses: 12 months Providers: 3 months … and 12 months post CPOE/EHR implementation). … , 12 months and 3 months respectively), but not for providers. … levels by 12 months.

457. Online Counseling to Enable Lifestyle-Focused Obesity Treatment in Primary Care - Final report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/r18hs018155-mctigue-final-report-2013.pdf
     January 01, 2013 - Results: All study arms lost weight at 6 months, with the largest effect size seen in the COI-­‐M group … Data Collection Data were collected at baseline, 6 -­‐months and 12-­‐months. … Weight change (95% CI) at baseline, 6 months and 12 Months Time Point W ei gh t ch an ge … , and was unchanged from baseline values in all groups at 12 months. … and then increased slightly over the final six months of intervention.

458. Evaluation of the Impact of Telemedicine on Management of Rheumatoid Arthritis - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/r21hs024540-ferucci-final-report-2019.pdf
     January 01, 2019 - , as well as follow-up contact at 6 and 12 months. … , as well as to follow-up contact by telephone at 6 and 12 months. … RAPID3 was measured at 6 and 12 months. … In-Person Only Telemedicine In-Person Only Baseline (n=57) 6 months (n=44) 12 months (n= … 35) Baseline (n=65) 6 months (n=45) 12 months (n=39) RAPID3, Mean (SD) 12.5 (5.4) 11.8

459. Ear-Infection Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_executive.pdf
     May 01, 2013 - of less than 3 months. … TT improved hearing through 9 months after surgery compared with watchful waiting (3–6 months: 8.8 … dB; 6–9 months: 4.2 dB) (high strength of evidence); TT improved hearing by 10 dB at 4 to 6 months … Adenoidectomy was superior to no treatment for hearing in one study at 6 months but not at 12 months … or in median days with hearing loss at 3 months.

460. Enhancing self-management of T2DM with an Automated Reminder and Feedback System - 2011 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/enhancing-self-management-t2dm-automated-reminder-and-feedback-system/annual-summary/2011
     January 01, 2011 - Three months later, at a second home visit, a study team member provided the participant with a standard … Additional home visits were conducted 9- and 15-months after enrollment. … HbA1c levels, demonstrated a significant decrease in HbA1c for all participants from baseline to 15 months … Those regularly using the system during the final phase of the study (months 9 to 15), had an average … Additionally, frequent users spent fewer hours in sedentary behavior at 15 months (3.8 versus 5.4 hours